Skip to content

4Accepted Sep 18, 1:41 PM ET

Clene (CLNN) CEO Robert Etherington Buys $50K of Stock

CLNNClene Inc.

Accepted (ET)

1:41 PM

Sep 18, 2026

Filed

Sep 18, 2026

Documents

1

Size

6.9 KB

Summary

Clene (CLNN) CEO Robert Etherington Buys $50K of Stock

Updated

What Happened
Robert Dee Etherington, President & CEO and a director of Clene Inc. (CLNN), acquired 15,244 shares of Clene common stock on September 16, 2026 at $3.28 per share, for a total purchase price of $50,000. The shares were bought directly from the company in a registered direct offering.

Key Details

  • Transaction date: 2026-09-16; Form 4 filed: 2026-09-18 (timely filing).
  • Price and amount: 15,244 shares at $3.28 per share; total = $50,000.
  • Purchase type: Registered direct offering; issuance approved by the board consistent with Rule 16b-3. (Footnote F1)
  • Beneficial ownership notes: Shares are held by RDE RX Ventures LLC (Mr. Etherington is manager) and the Etherington Revocable Trust (he is co-trustee); these entities’ holdings may be deemed beneficially owned by Mr. Etherington. (Footnotes F2–F3)
  • Shares owned after transaction: Not specified in the information provided in this summary.

Context
This was a straight purchase from the issuer (not an option exercise or gift). Purchases like this are often considered more informative than sales because they show an insider deploying personal capital into the company, though the size here is modest (~$50k). The board-approved offering and Rule 16b-3 reference indicate the transaction was structured to comply with insider-trading and short-swing profit rules.

AI-written summary · check the filing